ARMITA BAKHTMAND: Open Payments
NPI 1235916396 · SAN LEANDRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 28 payments from 11 companies in 2025. Trend: 2023 $15 · 2024 $764 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 12 | $95 |
| Sage Therapeutics, LLC | 4 | $70 |
| Supernus Pharmaceuticals, Inc. | 3 | $55 |
| Astellas Pharma US Inc | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| MILLICENT US INC | 1 | $24 |
| CooperSurgical, Inc. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| CONMED Corporation | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: ZURZUVAE, Qelbree, Veozah, GARDASIL 9, FEMLYV, Paragard T 380A, APTIOM, AIRSEAL.
Industry payments across CA — which companies pay providers there.
